Myocardial (123) I-metaiodobenzylguanidine washout and heart rate variability in asymptomatic subjects
- PMID: 22276623
- PMCID: PMC6931951
- DOI: 10.1111/j.1542-474X.2011.00475.x
Myocardial (123) I-metaiodobenzylguanidine washout and heart rate variability in asymptomatic subjects
Abstract
Background: Myocardial (123) I-metaiodobenzylguanidine (MIBG) kinetics reflect the integrity and function of cardiac presynaptic sympathetic nerve terminals. Heart rate variability (HRV) is an indicator of cardiac sympatho-vagal balance. However, the function of cardiac sympathetic nerve terminals as a modulator of HRV in asymptomatic subjects has remained elusive. In addition, the physiological background for different components of HRV is not fully established.
Methods: We evaluated the relationship between myocardial MIBG washout and HRV in 30 asymptomatic subjects with familial risk of coronary artery disease (CAD). Early and delayed myocardial MIBG uptakes as well as MIBG washout between these two scans were assessed. Myocardial perfusion at rest and during bicycle exercise was evaluated with (99m) Tc-sestamibi (MIBI). HRV was measured from 24-hour ambulatory ECG recordings.
Results: Myocardial MIBG washout averaged 40 ± 8%. The mean heart rate at rest was 76 ± 14 beats/min. Standard deviation of all normal RR intervals (SDNN) was 94 ± 22 ms and very low frequency (VLF) was 1625 ± 958 ms(2) on average. Myocardial MIBG washout correlated inversely with SDNN (r =-0.390; P < 0.05) and with VLF (r =-0.459; P < 0.01) component of HRV but not with heart rate at rest (r = 0.207, P = ns). All subjects had normal myocardial perfusion at rest and during exercise.
Conclusions: Increased cardiac presynaptic sympathetic nervous activity was related to reduced HRV in subjects with the risk of CAD but without evidence of myocardial ischemia or previous myocardial infarction. In addition, we found that VLF component of HRV includes information about sympathetic neural modulation of the heart rate.
© 2012, Wiley Periodicals, Inc.
Figures



Similar articles
-
Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy.J Nucl Med. 1999 Jun;40(6):904-10. J Nucl Med. 1999. PMID: 10452304
-
Iodine-123 metaiodobenzylguanidine myocardial imaging in haemodialysed patients asymptomatic for coronary artery disease: a preliminary report.Nucl Med Commun. 2011 Jun;32(6):515-21. doi: 10.1097/MNM.0b013e328344dfed. Nucl Med Commun. 2011. PMID: 21427625 Clinical Trial.
-
Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease.J Nucl Med. 2002 Jan;43(1):1-7. J Nucl Med. 2002. PMID: 11801695
-
Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy.Am J Cardiol. 1999 Jun 1;83(11):1548-51. doi: 10.1016/s0002-9149(99)00145-9. Am J Cardiol. 1999. PMID: 10363869
-
Complementary Role of Combined Indirect and Direct Cardiac Sympathetic (Hyper)Activity Assessment in Patients with Heart Failure by Spectral Analysis of Heart Rate Variability and Nuclear Imaging: Possible Application in the Evaluation of Exercise Training Effects.J Cardiovasc Dev Dis. 2022 Jun 5;9(6):181. doi: 10.3390/jcdd9060181. J Cardiovasc Dev Dis. 2022. PMID: 35735810 Free PMC article. Review.
Cited by
-
Heart rate variability associates with asymptomatic coronary atherosclerosis.Clin Auton Res. 2014 Feb;24(1):31-7. doi: 10.1007/s10286-013-0220-z. Epub 2013 Nov 30. Clin Auton Res. 2014. PMID: 24343834
-
Nonlinear Conte-Zbilut-Federici (CZF) Method of Computing LF/HF Ratio: A More Reliable Index of Changes in Heart Rate Variability.J Pharmacopuncture. 2016 Sep;19(3):207-212. doi: 10.3831/KPI.2016.19.021. J Pharmacopuncture. 2016. PMID: 27695629 Free PMC article.
-
Iodine-123 metaiodobenzylguanidine scintigraphy for the assessment of cardiac sympathetic innervation and the relationship with cardiac autonomic function in healthy adults using standardized methods.Nucl Med Commun. 2017 Jan;38(1):44-50. doi: 10.1097/MNM.0000000000000608. Nucl Med Commun. 2017. PMID: 27898646 Free PMC article.
References
-
- Simula S, Lakka T, Laitinen T, et al Cardiac adrenergic denervation in patients with non‐Q‐wave versus Q‐wave myocardial infarction. Eur J Nucl Med 2000;27:816–821. - PubMed
-
- Hartikainen J, Mustonen J, Kuikka J, et al Cardiac sympathetic denervation in patients with coronary artery disease without previous myocardial infarction. Am J Cardiol 1997;80:273–277. - PubMed
-
- Stanton MS, Tuli MM, Radtke NL, et al Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I‐123‐metaiodobenzylguanidine. J Am Coll Cardiol 1989;14:1519–1526. - PubMed
-
- Mäntysaari M, Kuikka J, Hartikainen J, et al Myocardial sympathetic nervous dysfunction detected with iodine‐123‐ MIBG is associated with low heart rate variability after myocardial infarction. J Nucl Med 1995;36:956–961. - PubMed
-
- Kline RC, Swanson DP, Wieland DM, et al Myocardial imaging in man with I‐123 meta‐iodobenzylguanidine. J Nucl Med 1981;22:129–132. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous